Learning Individual Survival Models from PanCancer Whole Transcriptome Data

Neeraj Kumar, Daniel Skubleny, Michael Parkes, Ruchika Verma, S. Davis, Luke Kumar, Amira Aissiou, Russell GreinerClinical 2023 · DOI

Abstract

NMF-MTLR provides many benefits over other models: superior model discrimination, superior calibration, meaningful survival time estimates, and accurate probabilistic estimates of survival over time for each individual patient. We advocate for the adoption of these cancer survival models in clinical and research settings.
BibTeX
@inproceedings{kumar2023learning,
  author = {Neeraj Kumar and Daniel Skubleny and Michael Parkes and Ruchika Verma and S. Davis and Luke Kumar and Amira Aissiou and Russell Greiner},
  title = {{Learning Individual Survival Models from PanCancer Whole Transcriptome Data}},
  booktitle = {Clinical},
  year = {2023},
  doi = {10.1158/1078-0432.ccr-22-3493},
}

Loading related content...

Figure